{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:04:48Z","timestamp":1790845488401,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.tjog.2021.11.008","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T18:20:15Z","timestamp":1644949215000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Circulating tumor cells as a \u201creal-time liquid biopsy\u201d: Recent advances and the application in ovarian cancer"],"prefix":"10.1016","volume":"61","author":[{"given":"Hei-Jen","family":"Jou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ying","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Tung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2021.11.008_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.critrevonc.2013.08.017","article-title":"Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer","volume":"89","author":"Colombo","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.tjog.2021.11.008_bib3","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1078-0432.CCR-13-2664","article-title":"Circulating tumor cells: a multifunctional biomarker","volume":"20","author":"Yap","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.tjog.2021.11.008_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tjog.2021.11.008_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor Metastasis: molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tjog.2021.11.008_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tjog.2021.11.008_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/10408360590913696","article-title":"Detection of disseminated tumor cells in peripheral blood","volume":"42","author":"Zieglschmid","year":"2005","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.tjog.2021.11.008_bib8","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1073\/pnas.95.8.4589","article-title":"Detection and characterization of carcinoma cells in the blood","volume":"95","author":"Racila","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tjog.2021.11.008_bib9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","article-title":"Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis","volume":"158","author":"Aceto","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tjog.2021.11.008_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2013.12.019","article-title":"Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer","volume":"346","author":"Lim","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.tjog.2021.11.008_bib11","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2013.51.7417","article-title":"Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase iii trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer","volume":"32","author":"Goldkorn","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib12","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1039\/C7CS00016B","article-title":"Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells","volume":"46","author":"Jackson","year":"2017","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.tjog.2021.11.008_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/mi10020132","article-title":"A\u00a0silicon-based coral-like nanostructured microfluidics to isolate rare cells in human circulation: validation by sk-br-3 cancer cell line and its utility in circulating fetal nucleated red blood cells","volume":"10","author":"Ma","year":"2019","journal-title":"Micromachines"},{"key":"10.1016\/j.tjog.2021.11.008_bib14","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.2741\/2911","article-title":"EpCAM expression in normal, non-pathological tissues","volume":"13","author":"Schmelzer","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.tjog.2021.11.008_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCam protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.tjog.2021.11.008_bib16","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1158\/0008-5472.CAN-04-0754","article-title":"EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy","volume":"64","author":"Osta","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.tjog.2021.11.008_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","article-title":"EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis","volume":"64","author":"Spizzo","year":"2011","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.tjog.2021.11.008_bib18","article-title":"Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin","volume":"7","author":"Po","year":"2018","journal-title":"J\u00a0Circ Biomark"},{"key":"10.1016\/j.tjog.2021.11.008_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.08.020","article-title":"Multifunctional magnetic nanowires: a novel breakthrough for ultrasensitive detection and isolation of rare cancer cells from non-metastatic early breast cancer patients using small volumes of blood","volume":"106","author":"Hong","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.tjog.2021.11.008_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/mi12050473","article-title":"An automatic platform based on nanostructured microfluidic chip for isolating and identification of circulating tumor cells","volume":"12","author":"Jou","year":"2021","journal-title":"Micromachines"},{"key":"10.1016\/j.tjog.2021.11.008_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2017.02.042","article-title":"Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer","volume":"145","author":"Lee","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/mi11080774","article-title":"Nanotechnology-assisted isolation and analysis of circulating tumor cells on microfluidic devices","volume":"11","author":"Cheng","year":"2020","journal-title":"Micromachines"},{"key":"10.1016\/j.tjog.2021.11.008_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50241-w","article-title":"High-throughput automated microscopy of circulating tumor cells","volume":"9","author":"Aguilar-Avelar","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.tjog.2021.11.008_bib24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00404-020-05477-7","article-title":"Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer","volume":"301","author":"Banys-Paluchowski","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.tjog.2021.11.008_bib25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/cells9051218","article-title":"Circulating tumor cells characterization revealed timp1 as a potential therapeutic target in ovarian cancer","volume":"14","author":"Abreu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.tjog.2021.11.008_bib26","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2019-0497","article-title":"Analysis of differentially expressed micrornas and circulating tumor cells as predictive biomarkers of platinum chemoresistance in primary ovarian carcinomas: a prospective study","volume":"24","author":"Lou","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.tjog.2021.11.008_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/labmed\/lmx084","article-title":"Assessment of circulating tumor cells as a predictive biomarker of histology in women with suspected ovarian cancer","volume":"49","author":"Lou","year":"2018","journal-title":"Lab Med"},{"key":"10.1016\/j.tjog.2021.11.008_bib28","doi-asserted-by":"crossref","first-page":"106415","DOI":"10.18632\/oncotarget.22468","article-title":"Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? A study of the OVCAD consortium","volume":"8","author":"Obermayr","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2021.11.008_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.06.022","article-title":"Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study","volume":"123","author":"Behbakht","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","article-title":"Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib32","doi-asserted-by":"crossref","first-page":"48820","DOI":"10.18632\/oncotarget.16179","article-title":"EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy","volume":"8","author":"Chebouti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2021.11.008_bib33","doi-asserted-by":"crossref","first-page":"24303","DOI":"10.18632\/oncotarget.13286","article-title":"ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer","volume":"8","author":"Chebouti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2021.11.008_bib34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.molonc.2016.04.002","article-title":"Gene expression profiling of single circulating tumor cells in ovarian cancer \u2013 establishment of a multi-marker gene panel","volume":"10","author":"Blassl","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib35","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1373\/clinchem.2014.224808","article-title":"ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance","volume":"60","author":"Kuhlmann","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.tjog.2021.11.008_bib36","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/IGC.0b013e318216cb91","article-title":"Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy","volume":"21","author":"Aktas","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tjog.2021.11.008_bib37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.20180765","article-title":"Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.tjog.2021.11.008_bib38","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.ejso.2016.05.010","article-title":"Current and future role of circulating tumor cells in patients with epithelial ovarian cancer","volume":"42","author":"Van Berckelaer","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib39","doi-asserted-by":"crossref","first-page":"77195","DOI":"10.18632\/oncotarget.20428","article-title":"Circulating tumor cells in the differential diagnosis of adnexal masses","volume":"8","author":"Suh","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2021.11.008_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2015.03.002","article-title":"Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)","volume":"137","author":"Pearl","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","article-title":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","volume":"134","author":"Pearl","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib42","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.18632\/oncotarget.23943","article-title":"Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer","volume":"9","author":"Guo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tjog.2021.11.008_bib43","doi-asserted-by":"crossref","first-page":"e15354","DOI":"10.1097\/MD.0000000000015354","article-title":"Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: a prospective observational study","volume":"98","author":"Kim","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.tjog.2021.11.008_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2012.09.021","article-title":"Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance \u2013 a study of the OVCAD consortium","volume":"128","author":"Obermayr","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib45","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3389\/fonc.2019.01015","article-title":"Soluble programmed death receptor ligands sPD-L1 and sPD-L2 as liquid biopsy markers for prognosis and platinum response in epithelial ovarian cancer","volume":"9","author":"Buderath","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib46","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1159\/000492521","article-title":"Analysis of circulating tumor cells in ovarian cancer and their clinical value as a biomarker","volume":"48","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.tjog.2021.11.008_bib47","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1038\/s41598-021-86122-4","article-title":"Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.tjog.2021.11.008_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/cells8070732","article-title":"Detection of abundant non-haematopoietic circulating cancer-related cells in patients with advanced epithelial ovarian cancer","volume":"8","author":"Kumar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tjog.2021.11.008_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2021.02.024","article-title":"Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: a meta-analysis","volume":"161","author":"Huang","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib50","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.celrep.2018.01.053","article-title":"Commonly occurring cell subsets in high-grade serous ovarian tumors identified by single-cell mass cytometry","volume":"22","author":"Gonzalez","year":"2018","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.tjog.2021.11.008_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-019-0187-3","article-title":"Liquid biopsy and minimal residual disease \u2013 latest advances and implications for cure","volume":"16","author":"Pantel","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.tjog.2021.11.008_bib52","first-page":"9599","article-title":"Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system","volume":"10","author":"Rao","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.tjog.2021.11.008_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2014.02.019","article-title":"Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization","volume":"433","author":"Ning","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.tjog.2021.11.008_bib54","doi-asserted-by":"crossref","first-page":"14055","DOI":"10.1021\/acsami.8b02583","article-title":"Folic acid targeting for efficient isolation and detection of ovarian cancer CTCs from human whole blood based on two-step binding strategy","volume":"10","author":"Nie","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.tjog.2021.11.008_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1039\/C5BM00207A","article-title":"Folic acid conjugated magnetic iron oxide nanoparticles for nondestructive separation and detection of ovarian cancer cells from whole blood","volume":"4","author":"Liu","year":"2016","journal-title":"Biomater Sci"},{"key":"10.1016\/j.tjog.2021.11.008_bib56","first-page":"973","article-title":"Molecular characterization of circulating tumor cells in ovarian cancer","volume":"6","author":"Kolostova","year":"2016","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.tjog.2021.11.008_bib57","first-page":"3363","article-title":"The added value of circulating tumor cells examination in ovarian cancer staging","volume":"5","author":"Kolostova","year":"2015","journal-title":"Am J Cancer Res"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455921003120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455921003120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:19:25Z","timestamp":1760897965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455921003120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1028455921003120"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2021.11.008","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor cells as a \u201creal-time liquid biopsy\u201d: Recent advances and the application in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2021.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}